ISSN : 2663-2187
-
Diagnostic Performance of IFAT, Blood and Lymph Node Culture and Rapid Tests in Canine Leishmaniasis and Their Association with Clinical Signs
Volume 6 | Issue - 16
-
Correlation between Frequency of Therapy Sessions and Quality of Life Index to Knee OA Grade Severity using TENS and USD
Volume 6 | Issue - 16
-
SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW 10- [2-SUBSTITUTEDIMINO-4-SUBSTITUTED AMINO)-1,3,5-DITHIAZINO] CHLOROPHENOTHIAZINES.
Volume 6 | Issue - 16
-
SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW 10- [2-SUBSTITUTEDIMINO-4-SUBSTITUTED AMINO)-1,3,5-DITHIAZINO] CHLOROPHENOTHIAZINES.
Volume 6 | Issue - 16
-
SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW 10- [2-SUBSTITUTEDIMINO-4-SUBSTITUTED AMINO)-1,3,5-DITHIAZINO] CHLOROPHENOTHIAZINES.
Volume 6 | Issue - 16
Comparison of Efficacy of Empagliflozin, Dapagliflozin, and Ertugliflozin in the Management of Type 2 Diabetes Mellitus
Main Article Content
Abstract
Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors, empagliflozin, dapagliflozin and ertugliflozin are part of modern therapy of T2DM. A wide range of these agents enhances glycemic control but has further cardiovascular and renal advantages that are crucial in modern T2DM management. Objectives : This research will therefore seek to comparing empagliflozin, dapagliflozin and ertugliflozin in the context of T2DM with regard to HbA1c and FPG management, alongside safety profiles. Study design: A retrospective cohort study.
